1. Medtech Insight
  2. >>Policy & Regulation

Journal Article Reprint Payments Reported In Sunshine Database Should Be “Put Into Context,” Sen. Grassley Says

Sen. Chuck Grassley, R-Iowa, April 10 pressed HHS Secretary Sebelius to be certain that financial data reported by device and drug companies to the forthcoming Open Payments database tied to the value of medical journal article reprints be put into context.

Sen. Chuck Grassley, R-Iowa, pressed HHS Secretary Kathleen Sebelius at an April 10 Senate hearing that providers want drug and device manufacturers to be able to “put into context” data on the value of medical journal articles reprints they give to physicians, before that information comes out in the publicly accessible Open Payments database that CMS will release this fall.

“I want you to say … that providers will have a chance to put that spending information into context,” Grassley told Sebelius.

More from Legislation

More from Policy & Regulation

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By Vibha Sharma

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.

Plans For Specific EU Orphan And Pediatric Device Expert Panel Need To Go Further

 
• By Amanda Maxwell

Moves are at last underway for a more specific focus on orphan and pediatric devices. They are a start; but experts are calling for more to support this sector.

First Alzheimer’s Disease Diagnostic Blood Test Cleared By FDA

 
• By Natasha Barrow

Fujirebio Diagnostics' Alzheimer's disease test, Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, has been cleared by the US FDA.